Patent · US Active

Polypeptide and antibody bound to polypeptide

US11479603B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

SHANGHAI YILE BIOTECHNOLOGY CO., LTD. · CN

Inventors

Xiumei Cai · Shanghai, CN
Ruping Dai · Shanghai, CN
Huamao WANG · Shanghai, CN

Key dates

Filing date	Aug 28, 2018
Grant date	Oct 25, 2022
Priority date	—
Expiry date	Aug 28, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/285
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An antibody for being specifically bound to a pro brain-derived neurotrophic factor (pro-BDNF) and a bound epitope. The antibody and the protein are used for treating autoimmune diseases. By inhibiting the activity induced by the pro-BDNF, rheumatoid arthritis, psoriasis, systemic lupus erythematosus, lupus nephriti, chronic obstructive pulmonary diseases, asthma or cystic fibrosis, multiple sclerosis and other autoimmune diseases are treated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.